190 related articles for article (PubMed ID: 32675407)
21. Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential.
Abushakra S; Porsteinsson A; Scheltens P; Sadowsky C; Vellas B; Cummings J; Gauthier S; Hey JA; Power A; Wang P; Shen L; Tolar M
J Prev Alzheimers Dis; 2017; 4(3):149-156. PubMed ID: 29182706
[TBL] [Abstract][Full Text] [Related]
22. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress.
Colton CA; Brown CM; Cook D; Needham LK; Xu Q; Czapiga M; Saunders AM; Schmechel DE; Rasheed K; Vitek MP
Neurobiol Aging; 2002; 23(5):777-85. PubMed ID: 12392781
[TBL] [Abstract][Full Text] [Related]
23. Cognitive deficits and disruption of neurogenesis in a mouse model of apolipoprotein E4 domain interaction.
Adeosun SO; Hou X; Zheng B; Stockmeier C; Ou X; Paul I; Mosley T; Weisgraber K; Wang JM
J Biol Chem; 2014 Jan; 289(5):2946-59. PubMed ID: 24324264
[TBL] [Abstract][Full Text] [Related]
24. A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer's disease mouse model.
Campagna J; Spilman P; Jagodzinska B; Bai D; Hatami A; Zhu C; Bilousova T; Jun M; Elias CJ; Pham J; Cole G; LaDu MJ; Jung ME; Bredesen DE; John V
Sci Rep; 2018 Dec; 8(1):17574. PubMed ID: 30514854
[TBL] [Abstract][Full Text] [Related]
25. The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol.
Kariv-Inbal Z; Yacobson S; Berkecz R; Peter M; Janaky T; Lütjohann D; Broersen LM; Hartmann T; Michaelson DM
J Alzheimers Dis; 2012; 28(3):667-83. PubMed ID: 22057027
[TBL] [Abstract][Full Text] [Related]
26. Hippocampus-related cognitive impairments in young apoE4 targeted replacement mice.
Salomon-Zimri S; Boehm-Cagan A; Liraz O; Michaelson DM
Neurodegener Dis; 2014; 13(2-3):86-92. PubMed ID: 24080852
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory interneuron progenitor transplantation restores normal learning and memory in ApoE4 knock-in mice without or with Aβ accumulation.
Tong LM; Djukic B; Arnold C; Gillespie AK; Yoon SY; Wang MM; Zhang O; Knoferle J; Rubenstein JL; Alvarez-Buylla A; Huang Y
J Neurosci; 2014 Jul; 34(29):9506-15. PubMed ID: 25031394
[TBL] [Abstract][Full Text] [Related]
28. The Effects of Gene-Environment Interactions Between Cadmium Exposure and Apolipoprotein E4 on Memory in a Mouse Model of Alzheimer's Disease.
Zhang L; Wang H; Abel GM; Storm DR; Xia Z
Toxicol Sci; 2020 Jan; 173(1):189-201. PubMed ID: 31626305
[TBL] [Abstract][Full Text] [Related]
29. Identification and modification of amyloid-independent phenotypes of APOE4 mice.
DiBattista AM; Dumanis SB; Newman J; Rebeck GW
Exp Neurol; 2016 Jun; 280():97-105. PubMed ID: 27085394
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer's disease pathogenesis.
Cao J; Huang M; Guo L; Zhu L; Hou J; Zhang L; Pero A; Ng S; El Gaamouch F; Elder G; Sano M; Goate A; Tcw J; Haroutunian V; Zhang B; Cai D
Mol Psychiatry; 2021 Sep; 26(9):4687-4701. PubMed ID: 32632205
[TBL] [Abstract][Full Text] [Related]
31. Aggregate Trends of Apolipoprotein E on Cognition in Transgenic Alzheimer's Disease Mice.
Watson Y; Nelson B; Kluesner JH; Tanzy C; Ramesh S; Patel Z; Kluesner KH; Singh A; Murthy V; Mitchell CS
J Alzheimers Dis; 2021; 83(1):435-450. PubMed ID: 34334405
[TBL] [Abstract][Full Text] [Related]
32. Extra-Hippocampal Learning Deficits in Young Apolipoprotein E4 Mice and Their Synaptic Underpinning.
Har-Paz I; Roisman N; Michaelson DM; Moran A
J Alzheimers Dis; 2019; 72(1):71-82. PubMed ID: 31561365
[TBL] [Abstract][Full Text] [Related]
33. The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease.
Shenk JC; Liu J; Fischbach K; Xu K; Puchowicz M; Obrenovich ME; Gasimov E; Alvarez LM; Ames BN; Lamanna JC; Aliev G
J Neurol Sci; 2009 Aug; 283(1-2):199-206. PubMed ID: 19342064
[TBL] [Abstract][Full Text] [Related]
34. APOE genotype and sex affect microglial interactions with plaques in Alzheimer's disease mice.
Stephen TL; Cacciottolo M; Balu D; Morgan TE; LaDu MJ; Finch CE; Pike CJ
Acta Neuropathol Commun; 2019 May; 7(1):82. PubMed ID: 31113487
[TBL] [Abstract][Full Text] [Related]
35. Association of amyloid burden, brain atrophy and memory deficits in aged apolipoprotein ε4 mice.
Yin J; Turner GH; Coons SW; Maalouf M; Reiman EM; Shi J
Curr Alzheimer Res; 2014 Mar; 11(3):283-90. PubMed ID: 24694076
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E4 causes age- and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice.
Leung L; Andrews-Zwilling Y; Yoon SY; Jain S; Ring K; Dai J; Wang MM; Tong L; Walker D; Huang Y
PLoS One; 2012; 7(12):e53569. PubMed ID: 23300939
[TBL] [Abstract][Full Text] [Related]
37. Deferoxamine enhances alternative activation of microglia and inhibits amyloid beta deposits in APP/PS1 mice.
Zhang Y; He ML
Brain Res; 2017 Dec; 1677():86-92. PubMed ID: 28963052
[TBL] [Abstract][Full Text] [Related]
38. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
Levi O; Dolev I; Belinson H; Michaelson DM
J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
[TBL] [Abstract][Full Text] [Related]
39. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM
Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217
[TBL] [Abstract][Full Text] [Related]
40. Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment.
Salomon-Zimri S; Glat MJ; Barhum Y; Luz I; Boehm-Cagan A; Liraz O; Ben-Zur T; Offen D; Michaelson DM
J Alzheimers Dis; 2016 Jun; 53(4):1443-58. PubMed ID: 27372644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
